INABIN8bio, Inc.

INAB Stock Price, Valuation & Chart | IN8bio, Inc.

Compare

$1.100+0.01 (+0.92%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology INAB intrinsic value INAB calculated fair value vs price

Overview Financials Dividends Ratios

INAB Historical price chart

INAB Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization10.55M

PE Ratio-0.68

EPS-1.62

Trading Volume6.72K

Today's High/Low1.11/1.08

Dividend Yield0.00

52 Week High/Low2.73/0.88

Shares Outstanding9.59M

INAB Financial Statement

INAB Analyst ratings

INAB Analysis & performance metrics

INAB Company profile

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of…

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and…

INAB Management team

Name

Position

Patrick McCall CPACFO

Chief Financial Officer & Secretary

Lawrence S. Lamb Ph.D.

Executive Vice President, Co-Founder & Chief Scientific Officer

Kate Rochlin Ph.D.COO

Chief Operating Officer

Tai-Wei HoCEO

Co-Founder, President, Chief Executive Officer & Director

Name

Position

Patrick McCall CPACFO

Chief Financial Officer & Secretary

Lawrence S. Lamb Ph.D.

Executive Vice President, Co-Founder & Chief Scientific Officer

Kate Rochlin Ph.D.COO

Chief Operating Officer

Tai-Wei HoCEO

Co-Founder, President, Chief Executive Officer & Director

Management Team

Patrick McCall CPACFO

Chief Financial Officer & Secretary

Lawrence S. Lamb Ph.D.

Executive Vice President, Co-Founder & Chief Scientific Officer

Kate Rochlin Ph.D.COO

Chief Operating Officer

Tai-Wei HoCEO

Co-Founder, President, Chief Executive Officer & Director

Management

Patrick McCall CPACFO

Chief Financial Officer & Secretary

Lawrence S. Lamb Ph.D.

Executive Vice President, Co-Founder & Chief Scientific Officer

Kate Rochlin Ph.D.COO

Chief Operating Officer

Tai-Wei HoCEO

Co-Founder, President, Chief Executive Officer & Director

Total 4 executives

INAB Frequently asked questions

What is IN8bio, Inc. (INAB) Stock Price?

Current stock price of IN8bio, Inc. (INAB) stock is $1.100. The stock price is +0.92% higher in the session. The intraday range can be seen from this page. Volume of IN8bio, Inc. (INAB) stock is 6.72K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the IN8bio, Inc. (INAB) stock price going up or down today?

The stock price of IN8bio, Inc. (INAB) can change with earnings, company news, and overall market sentiment. IN8bio, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the IN8bio, Inc. stock expensive at its current price?

Whether IN8bio, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for INAB on this page is -0.68. EPS on this page is -1.62. Compare those figures with peers and growth expectations before deciding if the current IN8bio, Inc. price is justified.

How has the stock price of IN8bio, Inc. (INAB) performed historically?

Historical performance for IN8bio, Inc. (INAB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how INAB reacted to past earnings and market events.

Should I buy IN8bio, Inc. (INAB) stock, at this price?

Buying IN8bio, Inc. (INAB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.